Oluwadi About · New Org. · Analysis · Reports · Trends · Blog ·
RTP

Life Sciences · Biotech · Research

Investors Companies Schools

Biotech / Pharmathe Research Triangle

IMMvention

Biotech / Pharma · Durham, NC
IMMvention develops oral BACH1 inhibitors, including a sickle cell disease candidate, in partnership with Novo Nordisk.
Founded
Region
the Research Triangle
People